Shitrit David, Nirit Lev, Shiran Sheely I, Izbicki Gabriel, Sofer Dov, Eldad Melamed, Kramer Mordechai R
Pulmonary Institute, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petah Tivka, Israel.
J Heart Lung Transplant. 2003 Aug;22(8):946-50. doi: 10.1016/s1053-2498(02)00804-5.
Progressive multifocal leukoencephalopathy (PML) is a sub-acute, demyelinating disease of the brain caused by a human polyomavirus. We describe a patient with the onset of PML 7 months after lung transplantation. The patient was treated with immunosuppressive modulation and cidofovir, a new anti-viral therapy for PML, with stabilization of the symptoms. We also review the 4 additional reports in the literature of PML after heart and lung transplantation. Progressive multifocal leukoencephalopathy may become more prevalent as the population of heart and lung transplantation recipients increases.